Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-06

Clinical Trial Update: Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation [Phase 4]

View source ↗

Summary

Phase 4 study using fMRI to explore brain activation and neurobiological predictors of response to lisdexamfetamine in adults with ADHD; results posted from the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: Jeffrey Newcorn | Conditions: ADHD | Phase 4 | Status: COMPLETED | Results posted: 2018-06-06